VOYAGER THERAPEUTICS INC (VYGR)

US92915B1061 - Common Stock

5.91  +0.13 (+2.25%)

After market: 5.91 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
37.4M
-78.14%
40.9M
9.36%
250.008M
511.27%
92.71M
-62.92%
74.077M
-20.10%
85.936M
16.01%
79.751M
-7.20%
112.59M
41.18%
81.515M
-27.60%
111.87M
37.24%
233.93M
109.11%
EBITDA
YoY % growth
-68.43M
-319.19%
-44.61M
34.81%
126.455M
383.47%
-68.238M
-153.96%
-122.978M
-80.22%
-111.027M
9.72%
-120.36M
-8.41%
-148.155M
-23.09%
-139.383M
5.92%
-89.25M
35.97%
219.61M
346.06%
EBIT
YoY % growth
-73.6M
-368.61%
-50.8M
30.98%
122.014M
340.19%
-73.779M
-160.47%
-118.875M
-61.12%
-109.818M
7.62%
-131.107M
-19.39%
-100.515M
23.33%
-162.733M
-61.90%
-161.616M
0.69%
-4.5M
97.22%
Operating Margin
-196.79%-124.21%48.80%-79.58%-160.48%-127.79%-164.40%-89.27%-199.64%-144.47%-1.92%
EPS
YoY % growth
-1.90
-300.00%
-1.22
35.79%
3.09
353.28%
-0.94
-130.32%
-1.57
-67.68%
-1.25
20.33%
-1.21
3.57%
-0.39
67.46%
-1.08
-175.32%
-0.50
54.01%
0.19
138.46%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.39
-131.15%
-0.55
-176.25%
-0.45
-149.33%
-0.46
-186.88%
-0.58
-49.75%
Revenue
Q2Q % growth
15.823M
-82.43%
8.005M
-58.98%
15.541M
-47.46%
15.847M
-35.66%
8.005M
-49.41%
EBITDA
Q2Q % growth
-23.613M
-140.36%
-37.74M
-151.82%
-38.76M
-302.20%
-40.8M
-305.57%
-40.8M
-72.79%
EBIT
Q2Q % growth
-27.397M
-150.68%
-43.357M
-167.92%
-33.1M
-170.76%
-34.749M
-152.17%
-50.005M
-82.52%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.16
72.88%
-0.460.3065.43%
Q2 2024
Q2Q % growth
-0.18
64.71%
-0.420.2456.91%
Q1 2024
Q2Q % growth
-0.20
-106.80%
-0.450.2555.44%
Q4 2023
Q2Q % growth
1.25
304.92%
-0.291.54524.68%
Q3 2023
Q2Q % growth
-0.59
-231.11%
-0.590.000.49%
Q2 2023
Q2Q % growth
-0.51
-2.00%
-0.580.0712.06%
Q1 2023
Q2Q % growth
2.94
625.00%
0.792.15273.52%
Q4 2022
Q2Q % growth
-0.61
-506.67%
-0.56-0.05-9.30%
Q3 2022
Q2Q % growth
0.45
167.16%
-0.320.77239.11%
Q2 2022
Q2Q % growth
-0.50
37.50%
-0.32-0.18-54.39%
Q1 2022
Q2Q % growth
-0.56
3.45%
-0.35-0.21-59.46%
Q4 2021
Q2Q % growth
0.15
134.88%
-0.320.47146.44%
Q3 2021
Q2Q % growth
-0.67
-129.52%
-0.740.079.71%
Q2 2021
Q2Q % growth
-0.80
-247.83%
-0.73-0.07-10.08%
Q1 2021
Q2Q % growth
-0.58
12.12%
-0.670.0913.32%
Q4 2020
Q2Q % growth
-0.43
-26.47%
-0.580.1525.40%
Q3 2020
Q2Q % growth
2.27
653.66%
-0.202.471,263.66%
Q2 2020
Q2Q % growth
-0.23
-179.31%
-0.730.5068.54%
Q1 2020
Q2Q % growth
-0.66
18.52%
-0.810.1518.21%
Q4 2019
Q2Q % growth
-0.34
51.43%
-0.820.4858.71%
Q3 2019
Q2Q % growth
-0.41
34.92%
-0.770.3646.88%
Q2 2019
Q2Q % growth
0.29
136.25%
-0.771.06137.78%
Q1 2019
Q2Q % growth
-0.81
-28.57%
0.59-1.40-236.19%
Q4 2018
Q2Q % growth
-0.70 -0.710.011.96%
Q3 2018
Q2Q % growth
-0.63 -0.810.1821.93%
Q2 2018
Q2Q % growth
-0.80 -0.69-0.11-16.29%
Q1 2018
Q2Q % growth
-0.63 -0.11-0.52-461.50%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
24.629M
433.79%
12.129M12.5M103.06%
Q2 2024
Q2Q % growth
29.578M
509.48%
9.65M19.928M206.51%
Q1 2024
Q2Q % growth
19.516M
-87.03%
9.603M9.913M103.23%
Q4 2023
Q2Q % growth
90.061M
6,104.07%
21.048M69.013M327.88%
Q3 2023
Q2Q % growth
4.614M
-88.77%
2.966M1.648M55.56%
Q2 2023
Q2Q % growth
4.853M
593.29%
1.632M3.221M197.37%
Q1 2023
Q2Q % growth
150.48M
21,397.14%
41.82M108.66M259.83%
Q4 2022
Q2Q % growth
-1.5M
-105.34%
4.271M-5.771M-135.12%
Q3 2022
Q2Q % growth
41.1M
2,640.00%
9.604M31.496M327.95%
Q2 2022
Q2Q % growth
700K
-50.00%
13.041M-12.341M-94.63%
Q1 2022
Q2Q % growth
700K
-89.23%
14.705M-14.005M-95.24%
Q4 2021
Q2Q % growth
28.1M
332.31%
14.837M13.263M89.39%
Q3 2021
Q2Q % growth
1.5M
-98.73%
2.186M-686K-31.38%
Q2 2021
Q2Q % growth
1.4M
-95.12%
4.867M-3.467M-71.23%
Q1 2021
Q2Q % growth
6.5M
-64.09%
5.523M977K17.69%
Q4 2020
Q2Q % growth
6.5M
-80.12%
13.584M-7.084M-52.15%
Q3 2020
Q2Q % growth
117.8M
477.45%
38.082M79.718M209.33%
Q2 2020
Q2Q % growth
28.7M
-37.74%
15.836M12.864M81.23%
Q1 2020
Q2Q % growth
18.1M
248.08%
13.817M4.283M31.00%
Q4 2019
Q2Q % growth
32.7M
1,535.00%
11.144M21.556M193.43%
Q3 2019
Q2Q % growth
20.4M
871.43%
7.792M12.608M161.81%
Q2 2019
Q2Q % growth
46.1M
1,673.08%
7.789M38.311M491.86%
Q1 2019
Q2Q % growth
5.2M
477.78%
49.248M-44.048M-89.44%
Q4 2018
Q2Q % growth
2M 2.775M-775K-27.93%
Q3 2018
Q2Q % growth
2.1M 3.001M-901K-30.02%
Q2 2018
Q2Q % growth
2.6M 2.856M-256K-8.96%
Q1 2018
Q2Q % growth
900K 20.355M-19.455M-95.58%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 14.5% 30.07% 34.42%
Revenue-4.9% 54.33% 26.08% 31.41%